345 related articles for article (PubMed ID: 12042777)
21. Potent and specific inhibition of retrovirus production by coexpression of multiple siRNAs directed against different regions of viral genomes.
Ye K; Jin S
Biotechnol Prog; 2006; 22(1):45-52. PubMed ID: 16454491
[TBL] [Abstract][Full Text] [Related]
22. HIV-1-specific RNA interference.
Boden D; Pusch O; Ramratnam B
Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of drug-resistant HIV-1 by RNA interference.
Huelsmann PM; Rauch P; Allers K; John MJ; Metzner KJ
Antiviral Res; 2006 Jan; 69(1):1-8. PubMed ID: 16290277
[TBL] [Abstract][Full Text] [Related]
24. RNA interference--a new weapon against HIV and beyond.
Kitabwalla M; Ruprecht RM
N Engl J Med; 2002 Oct; 347(17):1364-7. PubMed ID: 12397198
[No Abstract] [Full Text] [Related]
25. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication.
Westerhout EM; Vink M; Haasnoot PC; Das AT; Berkhout B
Mol Ther; 2006 Aug; 14(2):268-75. PubMed ID: 16697708
[TBL] [Abstract][Full Text] [Related]
26. Interfering HIV.
Nat Immunol; 2002 Jul; 3(7):609. PubMed ID: 12087418
[No Abstract] [Full Text] [Related]
27. Inhibition of bcr-abl and/or c-abl gene expression by small interfering, double-stranded RNAs: cross-talk with cell proliferation factors and other oncogenes.
Ohba H; Zhelev Z; Bakalova R; Ewis A; Omori T; Ishikawa M; Shinohara Y; Baba Y
Cancer; 2004 Sep; 101(6):1390-403. PubMed ID: 15368327
[TBL] [Abstract][Full Text] [Related]
28. Ezrin, Radixin, and Moesin (ERM) proteins function as pleiotropic regulators of human immunodeficiency virus type 1 infection.
Kubo Y; Yoshii H; Kamiyama H; Tominaga C; Tanaka Y; Sato H; Yamamoto N
Virology; 2008 May; 375(1):130-40. PubMed ID: 18295815
[TBL] [Abstract][Full Text] [Related]
29. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
[TBL] [Abstract][Full Text] [Related]
30. Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.
Lin YL; Mettling C; Portales P; Reynes J; Clot J; Corbeau P
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15590-5. PubMed ID: 12434015
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production.
Aparicio O; Razquin N; Zaratiegui M; Narvaiza I; Fortes P
J Virol; 2006 Feb; 80(3):1376-84. PubMed ID: 16415015
[TBL] [Abstract][Full Text] [Related]
32. Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.
Vankoningsloo S; de Longueville F; Evrard S; Rahier P; Houbion A; Fattaccioli A; Gastellier M; Remacle J; Raes M; Renard P; Arnould T
FEBS J; 2008 Jun; 275(11):2738-53. PubMed ID: 18422646
[TBL] [Abstract][Full Text] [Related]
33. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance.
Anderson J; Banerjea A; Akkina R
Oligonucleotides; 2003; 13(5):303-12. PubMed ID: 15000821
[TBL] [Abstract][Full Text] [Related]
34. Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages.
Song E; Lee SK; Dykxhoorn DM; Novina C; Zhang D; Crawford K; Cerny J; Sharp PA; Lieberman J; Manjunath N; Shankar P
J Virol; 2003 Jul; 77(13):7174-81. PubMed ID: 12805416
[TBL] [Abstract][Full Text] [Related]
35. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor.
Holen T; Amarzguioui M; Wiiger MT; Babaie E; Prydz H
Nucleic Acids Res; 2002 Apr; 30(8):1757-66. PubMed ID: 11937629
[TBL] [Abstract][Full Text] [Related]
36. DBR1 siRNA inhibition of HIV-1 replication.
Ye Y; De Leon J; Yokoyama N; Naidu Y; Camerini D
Retrovirology; 2005 Oct; 2():63. PubMed ID: 16232320
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of HIV-1 replication by siRNA targeting conserved regions of gag/pol.
Morris KV; Chung CH; Witke W; Looney DJ
RNA Biol; 2005 Jan; 2(1):17-20. PubMed ID: 17132935
[TBL] [Abstract][Full Text] [Related]
38. Design of extended short hairpin RNAs for HIV-1 inhibition.
Liu YP; Haasnoot J; Berkhout B
Nucleic Acids Res; 2007; 35(17):5683-93. PubMed ID: 17715143
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA.
Konstantinova P; de Vries W; Haasnoot J; ter Brake O; de Haan P; Berkhout B
Gene Ther; 2006 Oct; 13(19):1403-13. PubMed ID: 16708080
[TBL] [Abstract][Full Text] [Related]
40. Modulation of HIV-1 replication by RNA interference.
Jacque JM; Triques K; Stevenson M
Nature; 2002 Jul; 418(6896):435-8. PubMed ID: 12087358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
